Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.01% of ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

GSK PLC GSK shares rose 1.06% to £13.34 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the ...

Deutsche Bank has recently reduced GSK plc (GSK) stock to Hold rating, as announced on November 15, 2024, according to Finviz. Earlier, on November 12, 2024, Jefferies had reduced the stock from a Buy ...

Stock analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for GSK in a research report issued ...

Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...